Professor Peter Hoffmann was the President of the Australasian Proteomics Society from 2020-2025 and is the President elect of the international Human Proteome Organisation (HUPO). For two decades, Peter’s research has delved into the identification of low abundant proteins and the mapping of their posttranslational modifications and their use as potential biomarkers for early detection of diseases, one of the biggest challenges in proteomics. He is leader in the field of Mass Spectrometry Imaging, and his research group was the first to use this technology in Australia. He is Director of the NCRIS Bioplatforms Australia Node for Tissue Imaging Mass Spectrometry. He has experience transforming research into industry-relevant outcomes, forming OncoDX to commercialise patented biomarkers for the early detection of ovarian and gastric cancer.